SB
Samsara BioCapital’s Rhythm Pharmaceuticals RYTM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.19M | Sell |
50,476
-87,642
| -63% | -$5.54M | 0.65% | 18 |
|
|
2025
Q1 | $7.32M | Sell |
138,118
-34,529
| -20% | -$1.83M | 1.3% | 14 |
|
|
2024
Q4 | $9.66M | Hold |
172,647
| – | – | 1.33% | 13 |
|
|
2024
Q3 | $9.04M | Hold |
172,647
| – | – | 1.74% | 16 |
|
|
2024
Q2 | $7.09M | Hold |
172,647
| – | – | 1.48% | 17 |
|
|
2024
Q1 | $7.48M | Hold |
172,647
| – | – | 1.16% | 18 |
|
|
2023
Q4 | $7.94M | Sell |
172,647
-172,646
| -50% | -$7.94M | 1.23% | 16 |
|
|
2023
Q3 | $7.92M | Hold |
345,293
| – | – | 2.42% | 12 |
|
|
2023
Q2 | $5.69M | Hold |
345,293
| – | – | 1% | 20 |
|
|
2023
Q1 | $6.16M | Hold |
345,293
| – | – | 1.27% | 17 |
|
|
2022
Q4 | $10.1M | Hold |
345,293
| – | – | 2.16% | 13 |
|
|
2022
Q3 | $8.46M | Hold |
345,293
| – | – | 1.97% | 15 |
|
|
2022
Q2 | $1.43M | Hold |
345,293
| – | – | 0.38% | 39 |
|
|
2022
Q1 | $3.98M | Hold |
345,293
| – | – | 1% | 27 |
|
|
2021
Q4 | $3.45M | Buy |
345,293
+45,000
| +15% | +$449K | 0.67% | 28 |
|
|
2021
Q3 | $3.92M | Hold |
300,293
| – | – | 0.62% | 30 |
|
|
2021
Q2 | $5.88M | Buy |
300,293
+99,247
| +49% | +$1.94M | 0.73% | 24 |
|
|
2021
Q1 | $4.28M | Hold |
201,046
| – | – | 0.79% | 27 |
|
|
2020
Q4 | $5.98K | Sell |
201,046
-33,800
| -14% | -$1.01K | 0.6% | 18 |
|
|
2020
Q3 | $5.09M | Sell |
234,846
-41,443
| -15% | -$898K | 1.42% | 18 |
|
|
2020
Q2 | $6.16M | Hold |
276,289
| – | – | 1.98% | 14 |
|
|
2020
Q1 | $4.21M | Buy |
+276,289
| New | +$4.21M | 2.42% | 11 |
|